Literature DB >> 3383989

Influence of digestive secretions and food on intestinal absorption of nicardipine.

J C Delchier1, M Guerret, N Vidon, C Dubray, D Lavene.   

Abstract

The role of digestive absorption in the pharmacokinetics of nicardipine has been studied by the perfusion technique. Nicardipine (40 mg) was perfused in six healthy subjects at 5 ml/min for 2 h either in isotonic saline with (Experiment A) or without (B) an occlusive balloon isolating the test segment from digestive secretions, or in a nutrient solution (Experiment C). In Experiments A and B, 100% of nicardipine was absorbed from the jejunal lumen in a 25 cm test segment and in Experiment C it was slightly lower (94%). There was no relationship between the absorption of nicardipine and water movement or bile salt concentration in the jejunum. Nicardipine was already present in the first plasma sample taken after 15 min and the peak level was found at the end of the perfusion. The areas under the curves differed widely between subjects, because of interindividual variation in the first pass effect, but they were similar in Experiments A, B and C. The experimental data showed a good fit to a mode involving a two-phase absorption process. The first phase was associated with intestinal perfusion (zero order process) and the second with passage across the intestinal wall (1st order process). In three further healthy subjects, nicardipine in saline was perfused in the jejunum and then in the ileum on consecutive days. Mean plasma levels over time were similar. The study showed that absorption of nicardipine both from the jejunum and the ileum was complete and was especially rapid. The food-induced change in the kinetics of absorption from the jejunum was too small to affect the pharmacokinetic parameters of nicardipine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3383989     DOI: 10.1007/bf00614554

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  THE FUNCTION OF BILE SALTS IN FAT ABSORPTION. THE SOLVENT PROPERTIES OF DILUTE MICELLAR SOLUTIONS OF CONJUGATED BILE SALTS.

Authors:  A F HOFMANN
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs.

Authors:  S Higuchi; H Sasaki; Y Shiobara; T Sado
Journal:  Xenobiotica       Date:  1977-08       Impact factor: 1.908

3.  [Twenty four-hour intestinal water and electrolyte flow rates in normal man: assessment by the slow marker perfusion technique (author's transl)].

Authors:  P Emonts; N Vidon; J J Bernier; J C Rambaud
Journal:  Gastroenterol Clin Biol       Date:  1979-02

Review 4.  Gastrointestinal absorption of drugs.

Authors:  L F Prescott
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

Review 5.  The method of intraluminal perfusion of the human small intestine. I. Principle and technique.

Authors:  R Modigliani; J C Rambaud; J J Bernier
Journal:  Digestion       Date:  1973       Impact factor: 3.216

6.  Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption.

Authors:  D Evard; N Vidon; J Godbillon; M Bovet; M Duval; J P Schoeller; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

7.  The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.

Authors:  J Levenson; A C Simon; J Bouthier; B C Maarek; M E Safar
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

8.  First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine.

Authors:  M Bellet; Y Loria; A Lallemand
Journal:  J Cardiovasc Pharmacol       Date:  1985 Nov-Dec       Impact factor: 3.105

9.  [Acute and chronic effects of a new calcium blocker, nicardipine, on renal hemodynamics in arterial hypertension].

Authors:  M Chaignon; M Bellet; M Lucsko; C Rapoud; J Guédon
Journal:  Arch Mal Coeur Vaiss       Date:  1985-10

Review 10.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

View more
  4 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope.

Authors:  M Guerret; G Cheymol; M Hubert; C Julien-Larose; D Lavene
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

Authors:  C Rollin; O Chosidow; B Diquet; C Dutreuil; S Herson; J Revuz; J C Delchier
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Site-dependent small intestinal absorption of ranitidine.

Authors:  T Gramatté; E el Desoky; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.